Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.

MLA

Barden, Anne E., et al. “Specialized Proresolving Lipid Mediators in Humans with the Metabolic Syndrome after N-3 Fatty Acids and Aspirin.” The American Journal of Clinical Nutrition, vol. 102, no. 6, Dec. 2015, pp. 1357–64. EBSCOhost, https://doi.org/10.3945/ajcn.115.116384.

APA

Barden, A. E., Mas, E., Croft, K. D., Phillips, M., & Mori, T. A. (2015). Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin. The American Journal of Clinical Nutrition, 102(6), 1357–1364. https://doi.org/10.3945/ajcn.115.116384

Chicago

Barden, Anne E, Emilie Mas, Kevin D Croft, Michael Phillips, and Trevor A Mori. 2015. “Specialized Proresolving Lipid Mediators in Humans with the Metabolic Syndrome after N-3 Fatty Acids and Aspirin.” The American Journal of Clinical Nutrition 102 (6): 1357–64. doi:10.3945/ajcn.115.116384.